Treatment of Newly Diagnosed Rhabdomyosarcoma Using Molecular Risk Stratification and Liposomal Irinotecan Based Therapy in Children With Intermediate and High Risk Disease
Clinical trial NCT06023641 · RECRUITING
Trial details
- NCT number
- NCT06023641
- Sponsor
- St. Jude Children's Research Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-13
- Primary completion
- 2034-10-01
- Enrollment
- 135
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.